Item 8.01. Other Events.

On June 12, 2020, Pfenex Inc. issued a press release announcing that its commercialization partner, Alvogen, has launched Teriparatide Injection (also referred to as PF708 and Bonsity™) in the United States. A copy of the press release announcing the foregoing is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Item 9.01Financial Statements and Exhibits.



(d) Exhibits



               Exhibit No.   Description
               99.1            Press Release dated June 12, 2020.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses